EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+14.87%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$6.83B
AUM Growth
+$1.02B
(+18%)
Cap. Flow
+$289M
Cap. Flow
% of AUM
4.24%
Top 10 Holdings %
Top 10 Hldgs %
21.97%
Holding
934
New
39
Increased
207
Reduced
104
Closed
35
Top Buys
| 1 |
Intel
INTC
|
$19.9M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$17.3M |
| 3 |
Sunrun
RUN
|
$16.6M |
| 4 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
$15.3M |
| 5 |
NOVA
Sunnova Energy
NOVA
|
$14.9M |
Top Sells
| 1 |
HES
Hess
HES
|
$36.7M |
| 2 |
LGI Homes
LGIH
|
$12.5M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$11.3M |
| 4 |
Cummins
CMI
|
$10.4M |
| 5 |
Merck
MRK
|
$10.2M |
Sector Composition
| 1 | Technology | 34.29% |
| 2 | Healthcare | 17.66% |
| 3 | Consumer Discretionary | 9.75% |
| 4 | Industrials | 9.46% |
| 5 | Financials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ascendis Pharma
ASND
$12.5B
| $2.36M | 0.03% |
18,500
| – | – |
|
277
Krystal Biotech
KRYS
$4.35B
| $2.33M | 0.03% |
18,200
+12,800
| +237% | +$1.64M |
|
278
NetEase
NTES
$85B
| $2.32M | 0.03% |
26,000
| – | – |
|
279
Repligen
RGEN
$7.01B
| $2.32M | 0.03% |
+12,500
| New | +$2.32M |
|
280
Xenon Pharmaceuticals
XENE
$3.02B
| $2.32M | 0.03% |
50,000
+15,000
| +43% | +$695K |
|
281
The Mosaic Company
MOS
$10.3B
| $2.3M | 0.03% |
63,765
| – | – |
|
|
BPMC
282
DELISTED
Blueprint Medicines
BPMC
| $2.29M | 0.03% |
25,100
| – | – |
|
283
TSMC
TSM
$1.26T
| $2.27M | 0.03% |
21,820
| – | – |
|
|
ONC
284
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $2.26M | 0.03% |
12,600
| – | – |
|
285
Pinduoduo
PDD
$177B
| $2.18M | 0.03% |
15,000
| – | – |
|
286
Marriott International Class A Common Stock
MAR
$71.9B
| $2.17M | 0.03% |
9,700
| – | – |
|
287
Mondelez International
MDLZ
$79.9B
| $2.17M | 0.03% |
30,025
+21,758
| +263% | +$1.57M |
|
288
Cartesian Therapeutics
RNAC
$277M
| $2.16M | 0.03% |
104,233
+20,000
| +24% | +$415K |
|
289
Phillips 66
PSX
$53.2B
| $2.16M | 0.03% |
16,250
+5,950
| +58% | +$790K |
|
290
Marathon Petroleum
MPC
$54.8B
| $2.13M | 0.03% |
14,500
+2,500
| +21% | +$367K |
|
291
Vaxcyte
PCVX
$4.29B
| $2.13M | 0.03% |
33,600
+4,600
| +16% | +$291K |
|
292
Baidu
BIDU
$35.1B
| $2.12M | 0.03% |
18,000
| – | – |
|
293
Tenaris
TS
$18.2B
| $2.1M | 0.03% |
60,000
| – | – |
|
294
Legend Biotech
LEGN
$6.66B
| $2.08M | 0.03% |
34,700
| – | – |
|
295
Idexx Laboratories
IDXX
$51.4B
| $2.06M | 0.03% |
3,690
| – | – |
|
296
Jones Lang LaSalle
JLL
$14.8B
| $2.04M | 0.03% |
10,762
-3,015
| -22% | -$573K |
|
297
Immunovant
IMVT
$2.99B
| $1.93M | 0.03% |
+45,500
| New | +$1.93M |
|
298
Travelers Companies
TRV
$62B
| $1.87M | 0.03% |
9,900
| – | – |
|
|
IMGN
299
DELISTED
Immunogen Inc
IMGN
| $1.87M | 0.03% |
63,000
+16,000
| +34% | +$475K |
|
300
Infosys
INFY
$67.9B
| $1.86M | 0.03% |
100,000
| – | – |
|